GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medical Marijuana MJNA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

-50.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Medical Marijuana

Its shares trade under the ticker MJNA. It has been listed since 21 June 2004. In the fiscal year to 31 December 2025, it reported revenue of $12.5m and a net loss of $935,305. At that date it held total assets of $66.3m and shareholders' equity of $49.8m.

Medical Marijuana, Inc. engages in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids. The company is headquartered in Vista, California. The company went IPO on 2004-06-21. The company operates in three divisions. Medical Marijuana, Inc. division operates its Website to maintain an online presence, provide corporate, investor relations and educational information and news relating to it and the cannabis industry. HempMeds division distributes products directly in the United States and through its subsidiaries internationally primarily in Mexico and Brazil. The division's product is Real Scientific Hemp Oil (RSHO). RSHO is a full spectrum, complete CBD hemp oil, which contains the natural hemp oil in the industry. RSHO is offered in three varieties: Green, Blue and Gold. Kannaway is its direct selling division, which sells its CBD products in United States, Europe and Asia. Its product also includes Focus, which contains Nootropics that helps support cognitive function.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
21 Jun 2004

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • HempMeds division distributes RSHO in the US and internationally through Mexico and Brazil.
  • Kannaway sells CBD products in the US, Europe, and Asia with Focus containing nootropics.
  • RSHO offers three varieties: Green, Blue, and Gold full spectrum CBD hemp oil.

Weaknesses

  • The company's IPO was on 21 June 2004, which is over 20 years ago.
  • HempMeds operates primarily in Mexico and Brazil for international distribution.
  • Kannaway's product Focus contains nootropics for cognitive support in multiple regions.

Opportunities

  • Expanding RSHO distribution in Mexico and Brazil through HempMeds division.
  • Growing CBD market in Europe and Asia via Kannaway's direct selling division.
  • Increasing demand for full spectrum CBD hemp oil in the Health Care sector.

Threats

  • Regulatory challenges in the cannabis industry across multiple countries.
  • Competition from other CBD product manufacturers in the Health Care sector.
  • Potential legal restrictions on hemp oil distribution in international markets.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.